Pegarginase (Athenex)

N/A

Report date: 2024/11/20 20:00:31

Base Information

Drug NamePegarginase (Athenex)
Drug Alias NamePEG-arginase (Athenex)Pegtomarginase (Athenex)Pegylated arginase (Athenex)Pegylated Modified Human Arginase (Athenex)PT01 +[6] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionArginase replacements
TargetsArginine
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHong Kong Polytechnic University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAthenex Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A